Compare GBX & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBX | ENOV |
|---|---|---|
| Founded | 1974 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Fluid Controls |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2008 |
| Metric | GBX | ENOV |
|---|---|---|
| Price | $46.46 | $26.86 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $50.67 | $49.14 |
| AVG Volume (30 Days) | 334.5K | ★ 899.0K |
| Earning Date | 01-08-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ 27.96 | N/A |
| EPS | ★ 6.35 | N/A |
| Revenue | ★ $3,240,200,000.00 | $2,233,266,000.00 |
| Revenue This Year | N/A | $9.27 |
| Revenue Next Year | N/A | $4.56 |
| P/E Ratio | $7.33 | ★ N/A |
| Revenue Growth | N/A | ★ 11.57 |
| 52 Week Low | $37.77 | $25.47 |
| 52 Week High | $71.06 | $49.38 |
| Indicator | GBX | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 43.09 |
| Support Level | $46.02 | $26.16 |
| Resistance Level | $47.03 | $28.02 |
| Average True Range (ATR) | 1.02 | 1.15 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 41.90 | 44.74 |
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.